A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR) First published 26/01/2022 Last updated 17/09/2025 EU PAS number:EUPAS45356 Study Ongoing